| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
TAS-301
|
193620-69-8 |
TAS-31
|
3-[二(4-甲氧基苯基)亚甲基]-1,3-二氢-2H-吲哚-2-酮
|
C23H19NO3 |
357.407 | |
|
BS-181 Hydrochloride
|
1397219-81-6 |
BS181
|
BS181;BS 181;CS-979;BS-181 盐酸盐
|
C22H33ClN6 |
416.99062 | |
|
4EGI-1
|
315706-13-9 |
4EGI-1
|
CS-1408;ALPHA-[2-[4-(3,4-二氯苯基)-2-噻唑基]亚肼基]-2-硝基苯丙酸;CS-1896
|
C18H12Cl2N4O4S |
451.29 | 2017-001-1 |
|
4E1RCat
|
328998-25-0 |
4E1RCAT
|
4-[2,3-二氢-3-[[5-(4-硝基苯基)-2-呋喃基]亚甲基]-2-氧代-5-苯基-1H-吡咯-1-基]苯甲酸;CS-1228
|
C28H18N2O6 |
478.45232 | |
|
Jasplakinolide
|
102396-24-7 |
JASPLAKINOLIDE
|
|
C36H45BrN4O6 |
709.67 | |
|
GW791343 Hydrochloride
|
309712-55-8 |
GW791343 HCl
|
GW 791343 TRIHYDROCHLORIDE;GW-791343 TRIHYDROCHLORIDE;
|
C20H27Cl3F2N4O |
483.810386 | |
|
Prostratin
|
60857-08-1 |
酪氨酸激酶抑制剂
|
13-O-乙酰基-12-脱氧佛波醇;12-脱氧佛波醇-13-乙酸
|
C22H30O6 |
390.47 | |
|
Neuropeptide FF
|
99566-27-5 |
神经肽-FF
|
神经肽-FF;NEUROPEPTIDE FF肽
|
C54H76N14O10 |
1081.27 | |
|
Disulfiram
|
97-77-8 |
二硫化四乙基秋兰姆
|
双硫仑(双硫醒);二硫化四乙基秋兰姆;醇去氢酶;乙醇脱氢酶(ADH);二硫化四乙胺甲硫醯基;秋蘭姆;戒酒硫;双硫仑杂质;二硫化四乙基秋兰姆
|
C10H20N2S4 |
296.52 | 202-607-8 |
|
Troglitazone
|
97322-87-7 |
曲格列酮
|
曲格列酮;(+;-)-5-[4-[(6-羟基-2,5,7,8-四甲基苯并二氢吡喃-2-基)甲氧基]苄基]-2,4-噻唑烷二酮;5-[[4-[(3,4-二氢-6-羟基-2,8-四甲基-2H-1-苯并吡喃-2-基)甲氧基]苯基]甲基]-2,4-噻唑烷二酮;特洛格列酮;曲格列酮TROGLITAZONE;曲格列酮溶液,101PPM
|
C24H27NO5S |
441.54 | |
|
A 922500
|
959122-11-3 |
DGAT-1 抑制剂
|
(1R,2R)-2-[[4'-[[(苯基氨基)羰基]氨基][1,1'-联苯]-4-基]甲酰基]环戊烷羧酸;DGAT-1 抑制剂;DGAT-1 INHIBITOR 4A;A-922500;A922500
|
C26H24N2O4 |
428.486 | |
|
Tamibarotene
|
94497-51-5 |
他米巴罗汀
|
CS-1151;AM80;AM 80;AM-80;他米巴罗汀;4-[(5,5,8,8-四甲基-6,7-二氢萘-2-基)氨基甲酰]苯甲酸;TAMIBAROTENE,AM 80,AM-80,AM80;他米巴罗丁
|
C22H25NO3 |
351.44 | 1806241-263-5 |
|
Suplatast tosilate
|
94055-76-2 |
甲磺司特
|
(2-(4-(3-乙氧基-3-羟基丙氧基)苯基氨基甲酰)乙基)二甲基锍对甲苯磺酸盐;甲磺司特
|
C23H33NO7S2 |
499.64062 | |
|
KU-0063794
|
938440-64-3 |
KU-63794
|
5-[2-[(2R,6S)-2,6-二甲基-4-吗啉基]-4-(4-吗啉基)吡啶并[2,3-D]嘧啶-7-基]-2-甲氧基苯甲醇;CS-28;KU-0063794;KU 0063794;KU0063794
|
C25H31N5O4 |
465.551 | |
|
AC-55541
|
916170-19-9 |
AC-55541
|
AC55541;AC-55541
|
C25H20BrN5O3 |
518.362 | |
|
TCS 1102
|
916141-36-1 |
TCS 112
|
(2S)-N-[1,1'-联苯]-2-基-1-[2-[(1-甲基-1H-苯并咪唑-2-基)硫基]乙酰基]-2-吡咯烷甲酰胺
|
C27H26N4O2S |
470.58594 | |
|
H-Arg-Gly-Asp-Ser-OH
|
91037-65-9 |
RGDS
|
精氨酰-甘氨酰-天冬氨酰-丝氨酸,≥95%;精氨酸-甘氨酸-天冬氨酸-丝氨酸;甘氨酸-天冬氨酸;L-精氨酰甘氨酰-L-ALPHA-天冬氨酰-L-丝氨酸;精氨酰-甘氨酰-天冬氨酰-丝氨酸;RGDS PEPTIDE;FIBRONECTIN INHIBITOR;RGDS;天冬氨酸精氨酸
|
C15H27N7O8 |
433.42 | 1592732-453-0 |
|
ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2
|
90954-53-3 |
人类降钙素基因相关肽 1
|
人类降钙素基因相关肽 1;降钙素基因相关肽,人;ALA-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-MET-VAL-LYS-SER-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2(DISULFIDE BRIDGE CYS2-CYS7);ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2;VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2: VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2;降钙素基因(-20°C冷藏);ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2(CYS&CYS BRIDGE);降钙素基因相关肽,人,≥95%
|
C163H267N51O49S2 |
3789.31 | |
|
NEUROPEPTIDE Y (HUMAN, RAT)
|
90880-35-6 |
神经肽-Y (人, 鼠)
|
神经肽-Y,人体,鼠;神经肽-Y (人,鼠)
|
C189H284N55O57RS |
4270.67656 | |
|
CGK 733
|
905973-89-9 |
CGK 733
|
CGK-733;CGK 733;ALPHA-苯基-N-[2,2,2-三氯-1-[[[(4-氟-3-硝基苯基)氨基]硫代甲酰]氨基]乙基]-苯乙酰胺;CS-713
|
C23H18Cl3FN4O3S |
555.836423 |
药智官方微信
药智官方微博
